Assay interference and off-target liabilities of reported histone acetyltransferase inhibitors

[1]  Chunaram Choudhary,et al.  Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours , 2017, Nature.

[2]  Jürgen Bajorath,et al.  How Frequently Are Pan-Assay Interference Compounds Active? Large-Scale Analysis of Screening Data Reveals Diverse Activity Profiles, Low Global Hit Frequency, and Many Consistently Inactive Compounds. , 2017, Journal of medicinal chemistry.

[3]  Alexander Tropsha,et al.  Phantom PAINS: Problems with the Utility of Alerts for Pan-Assay INterference CompoundS , 2017, J. Chem. Inf. Model..

[4]  Jayme L. Dahlin,et al.  The Essential Medicinal Chemistry of Curcumin , 2017, Journal of medicinal chemistry.

[5]  J. Baell,et al.  Histone acetyltransferase inhibitors: where art thou? , 2016, Future medicinal chemistry.

[6]  F. Dekker,et al.  Histone acetyltransferases: challenges in targeting bi-substrate enzymes , 2016, Clinical Epigenetics.

[7]  A. Olson,et al.  Proteome-wide covalent ligand discovery in native biological systems , 2016, Nature.

[8]  Jayme L. Dahlin,et al.  How to Triage PAINS-Full Research. , 2016, Assay and drug development technologies.

[9]  Jonathan B Baell,et al.  Feeling Nature's PAINS: Natural Products, Natural Product Drugs, and Pan Assay Interference Compounds (PAINS). , 2016, Journal of natural products.

[10]  Julie M. Garlick,et al.  Characterizing the Covalent Targets of a Small Molecule Inhibitor of the Lysine Acetyltransferase P300. , 2016, ACS medicinal chemistry letters.

[11]  W. Sippl,et al.  KATching-Up on Small Molecule Modulators of Lysine Acetyltransferases. , 2016, Journal of medicinal chemistry.

[12]  Nancy Cheng,et al.  A cellular chemical probe targeting the chromodomains of Polycomb Repressive Complex 1 , 2015, Nature chemical biology.

[13]  Jayme L. Dahlin,et al.  Post-HTS case report and structural alert: Promiscuous 4-aroyl-1,5-disubstituted-3-hydroxy-2H-pyrrol-2-one actives verified by ALARM NMR. , 2015, Bioorganic & medicinal chemistry letters.

[14]  John P. Overington,et al.  The promise and peril of chemical probes. , 2015, Nature chemical biology.

[15]  Olivier Sperandio,et al.  FAF-Drugs3: a web server for compound property calculation and chemical library design , 2015, Nucleic Acids Res..

[16]  Jayme L. Dahlin,et al.  PAINS in the Assay: Chemical Mechanisms of Assay Interference and Promiscuous Enzymatic Inhibition Observed during a Sulfhydryl-Scavenging HTS , 2015, Journal of medicinal chemistry.

[17]  Jayme L. Dahlin,et al.  Histone-modifying enzymes, histone modifications and histone chaperones in nucleosome assembly: Lessons learned from Rtt109 histone acetyltransferases , 2015, Critical reviews in biochemistry and molecular biology.

[18]  R. Copeland,et al.  Small molecule control of chromatin remodeling. , 2014, Chemistry & biology.

[19]  C. Klein,et al.  Promiscuity and selectivity in covalent enzyme inhibition: a systematic study of electrophilic fragments. , 2014, Journal of medicinal chemistry.

[20]  P. Cole,et al.  Structure of the p300 Histone Acetyltransferase Bound to Acetyl-Coenzyme A and Its Analogues , 2014, Biochemistry.

[21]  Ethan Lee,et al.  Selective small molecule targeting β-catenin function discovered by in vivo chemical genetic screen. , 2013, Cell reports.

[22]  P. Kaufman,et al.  A small molecule inhibitor of fungal histone acetyltransferase Rtt109. , 2013, Bioorganic & medicinal chemistry letters.

[23]  Sahil Sharma,et al.  Design and Synthesis of Aza‐Flavones as a New Class of Xanthine Oxidase Inhibitors , 2013, Archiv der Pharmazie.

[24]  Ian A. Watson,et al.  Rules for identifying potentially reactive or promiscuous compounds. , 2012, Journal of medicinal chemistry.

[25]  K. Huberman,et al.  Characterisation of a Tip60 Specific Inhibitor, NU9056, in Prostate Cancer , 2012, PloS one.

[26]  Anil Vasudevan,et al.  Abbott Physicochemical Tiering (APT)--a unified approach to HTS triage. , 2012, Bioorganic & medicinal chemistry.

[27]  C. Bountra,et al.  Epigenetic protein families: a new frontier for drug discovery , 2012, Nature Reviews Drug Discovery.

[28]  W. Sippl,et al.  Small Molecule Inhibitors of Histone Acetyltransferases as Epigenetic Tools and Drug Candidates , 2012, Archiv der Pharmazie.

[29]  John E. Harlan,et al.  Iniparib Nonselectively Modifies Cysteine-Containing Proteins in Tumor Cells and Is Not a Bona Fide PARP Inhibitor , 2011, Clinical Cancer Research.

[30]  George Nikolakopoulos,et al.  An Efficient High-Throughput Screening Method for MYST Family Acetyltransferases, a New Class of Epigenetic Drug Targets , 2011, Journal of biomolecular screening.

[31]  W. Sippl,et al.  Synthesis and biological testing of novel pyridoisothiazolones as histone acetyltransferase inhibitors. , 2011, Bioorganic & medicinal chemistry.

[32]  Adrian Whitty,et al.  The resurgence of covalent drugs , 2011, Nature Reviews Drug Discovery.

[33]  Li-Rong Yu,et al.  Distinct roles of GCN5/PCAF‐mediated H3K9ac and CBP/p300‐mediated H3K18/27ac in nuclear receptor transactivation , 2011, The EMBO journal.

[34]  M. Goodman,et al.  The major α-tubulin K40 acetyltransferase αTAT1 promotes rapid ciliogenesis and efficient mechanosensation , 2010, Proceedings of the National Academy of Sciences.

[35]  Yanmin Yang,et al.  Faculty Opinions recommendation of MEC-17 is an alpha-tubulin acetyltransferase. , 2010 .

[36]  James Inglese,et al.  Apparent activity in high-throughput screening: origins of compound-dependent assay interference. , 2010, Current opinion in chemical biology.

[37]  Ruben Abagyan,et al.  Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor. , 2010, Chemistry & biology.

[38]  Peter Wipf,et al.  Profiling the NIH Small Molecule Repository for compounds that generate H2O2 by redox cycling in reducing environments. , 2010, Assay and drug development technologies.

[39]  Anton Simeonov,et al.  Molecular basis for the high-affinity binding and stabilization of firefly luciferase by PTC124 , 2010, Proceedings of the National Academy of Sciences.

[40]  J. Baell,et al.  New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. , 2010, Journal of medicinal chemistry.

[41]  Christopher P Austin,et al.  Quantitative analyses of aggregation, autofluorescence, and reactivity artifacts in a screen for inhibitors of a thiol protease. , 2010, Journal of medicinal chemistry.

[42]  H. Haisma,et al.  Inhibition of the PCAF histone acetyl transferase and cell proliferation by isothiazolones. , 2009, Bioorganic & medicinal chemistry.

[43]  Chih-Hung Lee,et al.  Tetrahydropyridine-4-carboxamides as novel, potent transient receptor potential vanilloid 1 (TRPV1) antagonists. , 2008, Bioorganic & medicinal chemistry.

[44]  Peter Wipf,et al.  Development of a 384-well colorimetric assay to quantify hydrogen peroxide generated by the redox cycling of compounds in the presence of reducing agents. , 2008, Assay and drug development technologies.

[45]  Maria Paola Costi,et al.  Comprehensive mechanistic analysis of hits from high-throughput and docking screens against beta-lactamase. , 2008, Journal of medicinal chemistry.

[46]  Ruili Huang,et al.  Fluorescence spectroscopic profiling of compound libraries. , 2008, Journal of medicinal chemistry.

[47]  Anthony M Giannetti,et al.  Surface plasmon resonance based assay for the detection and characterization of promiscuous inhibitors. , 2008, Journal of medicinal chemistry.

[48]  William A Weiss,et al.  Recognizing and exploiting differences between RNAi and small-molecule inhibitors. , 2007, Nature chemical biology.

[49]  Jean M. Severin,et al.  Toxicological evaluation of thiol-reactive compounds identified using a la assay to detect reactive molecules by nuclear magnetic resonance. , 2007, Chemical research in toxicology.

[50]  Christopher P Austin,et al.  A high-throughput screen for aggregation-based inhibition in a large compound library. , 2007, Journal of medicinal chemistry.

[51]  L. Honigberg,et al.  Discovery of Selective Irreversible Inhibitors for Bruton’s Tyrosine Kinase , 2007, ChemMedChem.

[52]  Jessica E. Bolden,et al.  Anticancer activities of histone deacetylase inhibitors , 2006, Nature Reviews Drug Discovery.

[53]  Brian K Shoichet,et al.  A detergent-based assay for the detection of promiscuous inhibitors , 2006, Nature Protocols.

[54]  P. Cole,et al.  Synthesis and evaluation of a potent and selective cell-permeable p300 histone acetyltransferase inhibitor. , 2005, Journal of the American Chemical Society.

[55]  Renaldo Mendoza,et al.  ALARM NMR: a rapid and robust experimental method to detect reactive false positives in biochemical screens. , 2005, Journal of the American Chemical Society.

[56]  T. Kundu,et al.  Polyisoprenylated Benzophenone, Garcinol, a Natural Histone Acetyltransferase Inhibitor, Represses Chromatin Transcription and Alters Global Gene Expression* , 2004, Journal of Biological Chemistry.

[57]  Tapas K. Kundu,et al.  Small Molecule Modulators of Histone Acetyltransferase p300* , 2003, Journal of Biological Chemistry.

[58]  W. Patrick Walters,et al.  A guide to drug discovery: Designing screens: how to make your hits a hit , 2003, Nature Reviews Drug Discovery.

[59]  J. Denu,et al.  The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase. , 2003, Molecular cell.

[60]  Xiao-Fan Wang,et al.  HDAC6 is a microtubule-associated deacetylase , 2002, Nature.

[61]  B. Shoichet,et al.  A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening. , 2002, Journal of medicinal chemistry.

[62]  R. Roeder,et al.  HATs off: selective synthetic inhibitors of the histone acetyltransferases p300 and PCAF. , 2000, Molecular cell.

[63]  Yingming Zhao,et al.  Structure of p300 in complex with acyl-CoA variants. , 2017, Nature chemical biology.

[64]  C. Arrowsmith,et al.  Chemical Biology Approaches for Characterization of Epigenetic Regulators. , 2016, Methods in enzymology.

[65]  George Nikolakopoulos,et al.  PAINS: Relevance to Tool Compound Discovery and Fragment-Based Screening , 2013 .

[66]  O. J. Trask,et al.  Assay Guidance Manual , 2004 .

[67]  D. Hupe,et al.  A spectrophotometric method for studying the rates of reaction of disulfides with protein thiol groups applied to bovine serum albumin , 1980 .